menu ☰
menu ˟

NICE gives green light to treatment for macular oedema in final draft guidance

01 Jan 2014
The National Institute for Health and Care Excellence (NICE) has published final draft guidance recommending aflibercept solution for injection (Eylea, Bayer) as an option for treating visual impairment caused by macular oedema, a condition which aff...

Click here to view the full article which appeared in National Institute for Health and Clinical Excellence (NICE)

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.